10.1016/0006-8993(85)91032-7 Summary Keywords Parkinson's disease, cerebrospinal fluid, biological markers, neurotransmitters, oxidative stress, tau protein, alpha-synuclein, beta-amyloid Citation Jimnez-Jimnez FJ, Alonso-Navarro H, Garca-Martn E and Agndez JAG (2014) Cerebrospinal fluid biochemical studies in patients with Parkinson's disease: toward a potential search for biomarkers for this disease
To verify whether GLP-1RAs@NPs-WYRGRL has the ability to target articular cartilage, GLP-1RAs@NPs and GLP-1RAs@NPs-WYRGRL were labeled with RBITC and injected into the experimental animals via the tail vein (Fig
Hosmer Lemeshow and pseudo- R square tests were checked, and no problems were found
It also has no aftertaste (e.g
To this day, several clinical trials are ongoing in a large panel of age-related diseases, but their validation remains uncertain (Table 1)